ClinicalTrials.gov
public full text
Public Domain
Combined Retinoic Acid,Arsenic Trioxide and Chemo for Newly-diagnosed APL
In this prospective randomized study for patients with newly diagnosed acute promyelocytic leukemia, patients will be randomized (1:1) into two groups which receive retinoic acid and arsenic trioxide based treatment versus retinoic acid and chemotherapy based regimen.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Tamibarotene and Arsenic Trioxide for Relapsed Acute Promyelocytic Leukemia#1114074
- Treatment of Relapsed Promyelocytic Leukemia With Arsenic Trioxide (ATO)#830927
- Frontline Oral Arsenic Trioxide for APL#1164531
- A Study for Oral SY-2101 for Participants With Acute Promyelocytic Leukemia#826037
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia#995650
Record · ID 1085492
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive